If you've lost a family member prematurely to heart disease, greater reassurance about your risk of suffering the same fate ...

Seeing is believing. Patients shown proof of calcification adhered better to statins; those without CAC avoided overtreatment ...

From hot dogs and potato chips to chicken nuggets and sugary sodas, Americans are eating more ultra-processed foods (UPFs) ...

Obesity has long been classified as a global epidemic — and new data published in The Lancet journal spotlights how much ...

Diabetes threatens more than just blood sugar levels - discover the major body systems at risk and how to recognize warning ...

Dr. Akshay Jain MD, FRCPC, FACE, CCD, ECNU, DABIM, DABOM, Clinical and Research Endocrinologist, talks about novel medications for diabetes that offer cardiovascular protection.

Metformin is the most commonly prescribed oral drug for diabetes. Of course, if you or a loved one receives treatment for ...

A large population-based cohort study reports that using GLP-1 RAs significantly reduces the risk for cardiovascular events ...

Metabolic diseases, encompassing obesity, diabetes, cardiovascular conditions, nonalcoholic fatty liver disease, hypertension, and metabolic syndrome, are ...

Heart disease is a silent epidemic that is having a disproportionate impact on the Black community in New York City’s neighborhoods.

GLP-1 receptor agonists were initially approved for glycaemic control in type 2 diabetes and, subsequently, for bodyweight loss in obesity. Following large-scale trials demonstrating that some GLP-1 ...

A widely used diabetes medication, SGLT2 inhibitors, has shown a surprising benefit for cancer patients—protecting their ...